Introduction: This study compares the relative prognostic power of clinical variables and quality-of-life (QoL) measures in a population of terminal cancer patients. Methods: A prospective cohort study in 58 Italian Palliative Care Units. Of the 601 randomly selected terminal cancer patients, 574 were followed until death in order to compare clinical and QoL variables (using the Therapy Impact Questionnaire (TIQ) as predictors of survival, and assess whether their combined implementation makes prediction more accurate. Results: The clinical variables most strongly associated with survival were dyspnoea, cachexia, Katz's ADL, oliguria, dysphagia, dehydration, liver and acute kidney failure and delirium (hazard ratios (HR) ranging from 2.10 to 3.01). Only the first four kept their strength once introduced in the Cox model (HRs ranging from 1.95 to 2.22). In the TIQ primary scale the strongest predictors were physical wellbeing, fatigue, functional status and cognitive status (HRs ranging from 1.42 to 1.71), but only fatigue showed an independent prognostic relevance (90% of selection). In the TIQ global scales, the Physical Symptom Index showed a stronger association with survival (HR 1.71) than the Therapy Impact Index (HR 1.47). The former marginally improved the prognostic power of the model when added to clinical variables. Internal validation confirmed that the results were not spurious. Conclusions: In terminal cancer patients, clinical variables are better predictors of survival than QoL. The large residual variability not accounted for by the model (: ≈ 70%) suggests that survival is also influenced by factors unlikely to be identified in a survey.
Christakis NA , Escarce JJ . Survival of Medicare patients after enrolment in hospice programs . N Engl J Med1996; 335: 172–178 .
2.
Hampe SO . Needs of the grieving spouse in a hospital setting . Nurs Res1975; 24: 113–120 .
3.
Wanzer SH , Adelstein SJ , Cranford RE , et al. The physician's responsibility toward hopelessly ill patients . N Engl J Med1984; 310: 955–959 .
4.
Glare P , Virik K , Jones M , et al. A systematic review of physicians' survival predictions in terminally ill cancer patients . BMJ1993; 327: 195–200 .
5.
Vigano A , Dorgan M , Bruera E , Suarez-Almazor ME . The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer . Cancer1999; 86: 170–176 .
6.
Knaus WA , Wagner DP , Zimmerman JE , Draper EA . Variation in mortality and length of stay in Intensive Care Units . Ann Intern Med1993; 118: 753–761 .
7.
Coates A , Gebski V , Bishop JF , et al. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies . N Engl J Med1987; 317: 1490–1495 .
8.
Coates A , Gebski V , Signorini D , et al. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer . J Clin Oncol1992; 10: 1833–1838 .
9.
Priestman T , Baum M , Jones V , Forbes J . Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer . Br Med J1977; 1: 1248–1250 .
10.
Ganz PA , Lee JJ , Siau J . Quality of life assessment: an independent prognostic variable for survival in lung cancer . Cancer1991; 67: 3131–3135 .
11.
Kaasa S , Mastekaasa A , Lund E . Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease: the importance of patients' subjective experience of disease and psychosocial well-being . Radiol Oncol1989; 15: 235–242 .
12.
Morris JN , Suissa S , Sherwood S , et al. Last days: a study of the quality of life of terminally ill cancer patients . J Chron Dis1986; 39: 47–62 .
13.
Spitzer WO , Dobson AJ , Hall J , et al. Measuring the quality of life of cancer patients . A concise QL-index for use by physicians J Chron Dis. 1981; 34: 585–597 .
14.
Addington-Hall JM , MacDonald LD , Anderson HR . Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care?Br J Cancer1990; 62: 695–699 .
15.
Llobera J , Esteva M , Rifa J , et al. Terminal cancer: duration and prediction of survival time . Eur J Cancer2000; 36: 2036–2043 .
16.
Shimozuma K , Sonoo H , Ichihara K , Tanaka K . The prognostic value of quality-of-life scores: preliminary results of an analysis of patients with breast cancer . Surg Today2000; 30: 255–261 .
17.
Allard P , Dionne A , Potvin D . Factors associated with length of survival among 1081 terminally ill cancer patients . J Palliat Care1995; 11: 20–24 .
18.
Anderson F , Dowing GM , Hill J . Palliative Performance Scale (PPS): a new tool . J Palliat Care1996; 12: 5–11 .
19.
Morita T , Tsunoda J , Inoue S , Chihara S . The Palliative Prognostic Index: a scoring system for survival prediction of terminally ill cancer patients . Support Care Cancer1999; 7: 128–133 .
20.
Loprinzi CL , Laurie JA , Wieand HS , et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group . J Clin Oncol1994; 12: 601–607 .
21.
Tamburini M , Brunelli C , Rosso S , Ventafridda V . Prognostic value of quality of life scores in terminal cancer patients . J Pain Symptom Manage1996; 11: 32–41 .
22.
Caraceni A , Nanni O , Maltoni M , et al. Impact of delirium on the short term prognosis of advanced cancer patients . Cancer2000; 89: 1145–1149 .
23.
Ruckdeschel JC , Piantadosi S , the LCSG . Quality of life assessment in lung surgery for bronchogenic carcinoma . Theoret Surg1991; 6: 201–205 .
24.
Toscani F , Medicine oboIC-oRGoP . Classification and staging of terminal cancer patients: rationale and objectives of a multicentre cohort prospective study and methods used . Support Care Cancer1996; 4: 56–60 .
25.
Costantini M , Toscani F , Gallucci M , et al. Terminal cancer patients and timing of referral to palliative care: a multicenter prospective cohort study . J Pain Symptom Manage1999; 18: 243–252 .
26.
Peruselli C , Di GP , Toscani F , et al. Home palliative care for terminal cancer patients: a survey on the final week of life . Palliat Med1999; 13: 233–241 .
27.
Paci E , Miccinesi G , Toscani F , et al. Quality of life assessment and outcome of palliative care . J Pain Symptom Manage2001; 21: 179–188 .
28.
McCarthy M , Higginson I . Clinical audit by a palliative care team . Palliat Med1991; 5: 215–221 .
29.
Katz S , Akpom CA . A measure of primary sociobiological functions . Int J Health Serv1976; 6: 493–508 .
30.
Tamburini M , Rosso S , Gamba A , et al. A therapy impact questionnaire for quality-of-life assessment in advanced cancer research . Ann Oncol1992; 3: 565–570 .
31.
Cox DR . Regression models and life tables (with discussion) . J R Statist Soc1972; 34: 187–220 .
32.
Sauberei W , Schumacher M . A bootstrap resampling procedure for model building: application to the Cox regression model . Stat Med1992; 11: 2093–2109 .
33.
Nagelkerke NJD . A note on the general definition of the coefficient of determination . Biometrika1991; 78: 691–692 .
34.
Sneeuw KC , Aaronson NK , Sprangers MA , et al. Value of caregiver ratings in evaluating the quality of life of patients with cancer . J Clin Oncol1997; 15: 1206–1217 .
35.
Brunelli C , Costantini M , Di GP , et al. Quality of life evaluation: when do terminal cancer patients and health care providers agree?J Pain Symptom Manage1998; 15: 151–158 .
36.
Harrington DP , Fleming TR . A class of rank test procedures for censored survival data . Biometrika1982; 69: 553–566 .
37.
Constans T , Bruyere A , Grab B , Rapin CH . PINI as a mortality index in hospitalized elderly patients. Research note . Int J Vitam Nutr Res1992; 62: 191-191 .
38.
Salamagne ME , Vinat-Binam P . Valeur prgnostique de parameters biologiques de nutrition chez des patients hospitalises en uniteá de soins palliatifs . InfoKara1996; 44: 21–32 .
39.
Grandi GE , Todd CJ , Borday SIG , Farquar MC . Does hospital at home for palliative care facilitate death at home? Randomised clinical trial . BMJ1999; 319: 1472–1475 .
40.
Guyatt GH , Deyo RA , Charlson M , et al. Responsiveness and validity in health status measurement: a clarification . J Clin Epidemiol1989; 42: 403–408 .
41.
Buccheri G , Ferrigno D , Tamburini M . Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study on 536 patients from a single institution . Eur J Cancer1996; 32: 1135–1141 .
42.
Schonwetter RS , Teasdale TA , Storey P . The terminal cancer syndrome . Arch Intern Med1989; 149: 965–966 .
43.
Wachtel T , Allen-Masterson S , Reuben D , et al. The end stage cancer patient: terminal common pathway . Hospice J1988; 4: 43–80 .
44.
Hulter AK . Disability as a predictor of outcome for the elderly in a department of internal medicine. A comparison of predictions based on index of ADL and physician predictions . Scand J Soc Med1987; 15: 261–265 .
45.
Forster LE , Lynn J . The use of physiologic measures and demographic variables to predict longevity among in-patient hospice applicants . Am J Hospice Care1989; 2: 31–34 .
46.
Bruera E , Miller MJ , Kuehn N , et al. Estimated survival of patients admitted to a palliative care unit: a prospective study . J Pain Symptom Manage1992; 7: 82–86 .
47.
Goodwin JS , Samet JM , Hunt WC . Determinants of survival in older cancer patients . J Natl Cancer Inst1996; 88: 1301–1308 .
48.
Pirovano M , Maltoni M , Nanni O , et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients . J Pain Symptom Manage1999; 17: 231–239 .
49.
Maltoni M , Nanni O , Pirovano M , et al. Successful validation of the palliative prognostic score in terminally ill cancer patients . J Pain Symptom Manage1999; 17: 240–247 .
50.
Marubini E , Valsecchi MG . Analysing survival data from clinical trials and observational studies. Chichester: John Wiley and Sons , 1995.
51.
den Daas N . Estimating length of survival in end-stage of cancer: a review of the literature . J Pain Symptom Manage1995; 10: 548–555 .
52.
Lynn J . Caring at the end of our lives . N Engl J Med1996; 335: 201–202 .
